To evaluate whether the expression of the 94 DEGs was related to survival prediction, measured as DFS or OS, we analyzed the 94 DEGs individually using a database with expression information of 109 patients with HER+/ER-/PR-, and data were obtained from TCGA breast ductal carcinoma study. The gene discussed is ESR1; the disease is breast ductal adenocarcinoma.